Diagnosis and acute management of migraine.
作者信息
Tzankova Velina, Becker Werner J, Chan Tommy L H
机构信息
Division of Neurology, Department of Medicine (Tzankova), University of Toronto, Toronto, Ont.; Department of Clinical Neurosciences and Hotchkiss Brain Institute (Becker), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Department of Clinical Neurological Sciences (Chan), Western University, London, Ont.
出版信息
CMAJ. 2023 Jan 30;195(4):E153-E158. doi: 10.1503/cmaj.211969.
Abstract
摘要
相似文献
1
Diagnosis and acute management of migraine.偏头痛的诊断与急性处理
CMAJ. 2023 Jan 30;195(4):E153-E158. doi: 10.1503/cmaj.211969.
2
Acute migraine treatment.急性偏头痛治疗
Headache. 2015 Jan;55(1):1-2. doi: 10.1111/head.12504.
3
The diagnosis and management of migraine.偏头痛的诊断与管理
East Afr Med J. 1995 Aug;72(8):477-8.
4
Migraine management in children.儿童偏头痛管理。
Curr Neurol Neurosci Rep. 2015 May;15(5):20. doi: 10.1007/s11910-015-0540-6.
5
Basic and Clinical Advances in the Diagnosis and Management of Migraine.偏头痛诊断与管理的基础与临床进展
Pain Res Manag. 2020 Mar 12;2020:8958143. doi: 10.1155/2020/8958143. eCollection 2020.
6
Migraine as a process - challenges in the effective management of migraine.偏头痛作为一个过程——偏头痛有效管理中的挑战。
Funct Neurol. 2008 Jul-Sep;23(3):153-60.
7
Principles of migraine diagnosis and management. A synthesis.偏头痛的诊断与管理原则。综述。
Postgrad Med. 2005 May;117(5 Suppl):26-8. doi: 10.3810/pgm.05.2005.suppl41.212.
8
How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?国际头痛疾病分类第3版（试行版）在现实生活中的偏头痛诊断和管理方面效果如何？
Curr Pain Headache Rep. 2016 Dec;20(12):66. doi: 10.1007/s11916-016-0599-z.
9
Managing Migraine Headaches in Children and Adolescents.儿童和青少年偏头痛的管理
Expert Rev Clin Pharmacol. 2016;9(3):477-82. doi: 10.1586/17512433.2016.1135050. Epub 2016 Jan 29.
10
Migraine Management in the Emergency Department.急诊科的偏头痛管理
J Emerg Nurs. 2020 Jul;46(4):518-523. doi: 10.1016/j.jen.2020.04.002. Epub 2020 Jun 6.
引用本文的文献
1
Noninvasive Vagus Nerve Stimulation for Cluster Headache and Migraine: A Health Technology Assessment.用于丛集性头痛和偏头痛的非侵入性迷走神经刺激：一项卫生技术评估
Ont Health Technol Assess Ser. 2025 May 1;25(2):1-177. eCollection 2025.
2
Association between serum vitamin D and severe headache or migraine: A population-based analysis.血清维生素D与重度头痛或偏头痛之间的关联：一项基于人群的分析。
PLoS One. 2025 Jan 3;20(1):e0313082. doi: 10.1371/journal.pone.0313082. eCollection 2025.
3
A Discrete-Choice Experiment Assessing the Patient Preferences and Real-World Experiences of Patients with Migraine in Japan.一项评估日本偏头痛患者的患者偏好和真实世界体验的离散选择实验。
Neurol Ther. 2024 Dec;13(6):1661-1683. doi: 10.1007/s40120-024-00663-0. Epub 2024 Sep 30.
4
Neurasites-A Standardized Plant Extract in the Treatment and Prevention of Migraine Attacks.神经通——一种用于治疗和预防偏头痛发作的标准化植物提取物。
J Clin Med. 2024 Jun 7;13(12):3364. doi: 10.3390/jcm13123364.
5
New perspectives on migraine treatment: a review of the mechanisms and effects of complementary and alternative therapies.偏头痛治疗的新视角：补充和替代疗法的机制与效果综述
Front Neurol. 2024 May 9;15:1372509. doi: 10.3389/fneur.2024.1372509. eCollection 2024.
6
Neuroimmunological effects of omega-3 fatty acids on migraine: a review.ω-3脂肪酸对偏头痛的神经免疫作用：综述
Front Neurol. 2024 May 6;15:1366372. doi: 10.3389/fneur.2024.1366372. eCollection 2024.
7
The effectiveness of agomelatine on headache severity and frequency in episodic migraine without aura; a parallel randomized controlled trial study.阿戈美拉汀治疗无先兆偏头痛发作期头痛严重程度和频率的有效性：一项平行随机对照试验研究。
BMC Neurol. 2024 Jan 2;24(1):2. doi: 10.1186/s12883-023-03516-9.
8
Ominous Causes of Headache.头痛的严重病因
Curr Pain Headache Rep. 2024 Mar;28(3):73-81. doi: 10.1007/s11916-023-01202-6. Epub 2023 Dec 13.
9
The Epigenetics of Migraine.偏头痛的表观遗传学。
Int J Mol Sci. 2023 May 23;24(11):9127. doi: 10.3390/ijms24119127.
10
Pharmacologic prevention of migraine.偏头痛的药物预防
CMAJ. 2023 Feb 6;195(5):E187-E192. doi: 10.1503/cmaj.221607.
本文引用的文献
1
Pharmacologic prevention of migraine.偏头痛的药物预防
CMAJ. 2023 Feb 6;195(5):E187-E192. doi: 10.1503/cmaj.221607.
2
Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis.新型药物与曲普坦类药物治疗偏头痛的比较：系统评价和荟萃分析。
JAMA Netw Open. 2021 Oct 1;4(10):e2128544. doi: 10.1001/jamanetworkopen.2021.28544.
3
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.美国头痛学会共识声明：更新将新的偏头痛治疗方法整合到临床实践中的建议。
Headache. 2021 Jul;61(7):1021-1039. doi: 10.1111/head.14153. Epub 2021 Jun 23.
4
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.口服rimegepant 用于偏头痛的预防性治疗：一项 2/3 期、随机、双盲、安慰剂对照试验。
Lancet. 2021 Jan 2;397(10268):51-60. doi: 10.1016/S0140-6736(20)32544-7. Epub 2020 Dec 15.
5
Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019.偏头痛仍是全球致残原因中的第二位，在年轻女性中则位居首位：全球疾病负担研究2019的结果。
J Headache Pain. 2020 Dec 2;21(1):137. doi: 10.1186/s10194-020-01208-0.
6
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.乌布列彭特用于偏头痛急性治疗的长期安全性评价：第 3 阶段，随机，52 周扩展试验。
Headache. 2020 Jan;60(1):141-152. doi: 10.1111/head.13682.
7
Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline.偏头痛的神经影像学：美国头痛学会系统评价和循证指南。
Headache. 2020 Feb;60(2):318-336. doi: 10.1111/head.13720. Epub 2019 Dec 31.
8
Ubrogepant for the Treatment of Migraine.乌布罗苷肽治疗偏头痛。
N Engl J Med. 2019 Dec 5;381(23):2230-2241. doi: 10.1056/NEJMoa1813049.
9
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.Ubrogepant 与安慰剂在偏头痛急性治疗中对疼痛及最困扰相关症状的影响：ACHIEVE II 随机临床试验。
JAMA. 2019 Nov 19;322(19):1887-1898. doi: 10.1001/jama.2019.16711.
10
ACR Appropriateness Criteria® Headache.ACR 适宜性标准®头痛。
J Am Coll Radiol. 2019 Nov;16(11S):S364-S377. doi: 10.1016/j.jacr.2019.05.030.
Zotero 插件